NSF Nominee Applies Skills To Chart Policy

WASHINGTON--As far as nuclear chemist Frederick Bernthal is concerned, democracy works. The man whom President Bush has picked to be the next deputy director of the National Science Foundation is a shining example of a scientist whose thoughts in midcareer turned to government and who has wound up playing a major role in federal science policy. "There are two kinds of political appointees," says physicist John Ahearne, the executive director of Sigma Xi, the scientific research society, and, l

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON--As far as nuclear chemist Frederick Bernthal is concerned, democracy works. The man whom President Bush has picked to be the next deputy director of the National Science Foundation is a shining example of a scientist whose thoughts in midcareer turned to government and who has wound up playing a major role in federal science policy.

"There are two kinds of political appointees," says physicist John Ahearne, the executive director of Sigma Xi, the scientific research society, and, like Bernthal, a former member of the Nuclear Regulatory Commission (NRC). "One group has a powerful mentor who rewards them for faithful political service. The other group is promoted for their competence, their specialized knowledge, and their administrative skills. Fred's definitely the second type."

Last month Bush announced his intention to nominate Bernthal to the spot vacated by economist John Moore (The Scientist, Jan. 8, 1990, page 9). The position is one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies